GO
Loading...
 

Bullish on Biotechs

Wed 04 Apr 12 | 02:34 PM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

Bullish on Biotechs

Wed 04 Apr 12 | 02:34 PM ET
Keryx Biopharma is down more than 70 percent after one of its colon cancer drugs failed a late stage clinical trial, with Mark Tepper, Strategic Wealth Partners managing partner.

Topics:

Technology  | Economy (U.S.)  | Stock Market  | Stock Picks  | Investing Technology

Sectors:

 | Biotechnology

Sectors:

 | Health Care
 
RELATED ARTICLES AND CONTENT
More Videos
Latest Videos
Luxury rental boom ... in Jersey
Fri 18 Apr 14 | 12:00 PM ET
Latest Videos
Great growth expectations
Fri 18 Apr 14 | 11:00 AM ET
Latest Videos
Remodeling & insurance costs
Fri 18 Apr 14 | 09:00 AM ET
Go
Displaying results for: Latest Video | US